Monitoring Glucose Levels in Patients With Myocardial Infarction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-04-30

Study Completion Date

2018-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the OptiScanner® for continuous glucose monitoring as a tool to optimize glucose levels in patients hospitalized for acute coronary syndromes

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Retinal Function in Relation to Glucose Changes

NCT00973726

Diabetes

UNKNOWN NA

INTERPRET - International Report on Routine Practice of Sensor-enabled Pump Therapy

NCT00790088

Diabetes Mellitus, Type 1

COMPLETED

Retinal Function in Relation to Long Term Changes in the Glucose Level

NCT00973401

Diabetes Mellitus

UNKNOWN

Changes in the Diameter of Retinal Vessels After Remote Ischemic Conditioning in Patients With Type 1 Diabetes

NCT03906383

Retinal Ischemia Diabetes Complications Ischemia +1 more

COMPLETED NA

Measurement of Total Retinal Blood Flow and Oxygen Extraction in Patients With Diabetes and Healthy Subjects

NCT03552562

Retinal Blood Flow

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methodology Part a) Explorative Part b) Randomised, parallel-group design

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndromes Hyperglycemia Hypoglycemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Glucose monitoring by OptiScanner®

Glucose monitoring and intervention guided by OptiScanner®

Group Type OTHER

OptiScanner®

Intervention Type DEVICE

1. Glucose monitoring by OptiScanner® for 48 h
2. Glucose lowering intervention (insulin) guided by OptiScanner®

Blinded continuous glucose monitoring

Blinded continuous glucose monitoring by OptiScanner® and glucose lowering intervention guided by routine glucose measurements

Group Type OTHER

OptiScanner®

Intervention Type DEVICE

1. Glucose monitoring by OptiScanner® for 48 h
2. Glucose lowering intervention (insulin) guided by OptiScanner®

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OptiScanner®

1. Glucose monitoring by OptiScanner® for 48 h
2. Glucose lowering intervention (insulin) guided by OptiScanner®

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute coronary syndrome according to the joint recommendations by the European Society of Cardiology (48, 49)
* Signed written informed consent consistent with Helsinki declaration and local legislations prior to participation in the trial.

Exclusion Criteria

* \<18 years old.
* Congestive heart failure.
* Patients who, in the opinion of the investigator, will have difficulties to comply with the protocol (examples: alcohol or drug abuse, psychiatric disorder).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No